These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8652277)

  • 1. Vinorelbine and epirubicin in metastatic breast cancer. A dose finding study.
    Blomqvist C; Hietanen P; Teerenhovi L; Rissanen P
    Eur J Cancer; 1995 Dec; 31A(13-14):2406-8. PubMed ID: 8652277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I study of high-dose epirubicin and vinorelbine in previously untreated non-small-cell lung cancer stage IIIB-IV.
    Bakker M; Groen HJ; Smit EF; Smeets J; Riggi M; Postmus PE
    Br J Cancer; 1995 Dec; 72(6):1547-50. PubMed ID: 8519675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vinorelbine, epirubicin and fluorouracil as first-line therapy in metastatic breast cancer--a phase II trial.
    Elomaa I; Joensuu H; Blomqvist C
    Acta Oncol; 2003; 42(4):309-14. PubMed ID: 12899502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined epirubicin and vinorelbine as first-line therapy in metastatic breast cancer: a pilot study performed by the Danish Breast Cancer Cooperative Group.
    Ejlertsen B; Højris I; Hansen S; Møholt K; Kristensen B; Mouridsen HT; Andersen J; Rose C; Kjaer M
    Breast; 2003 Feb; 12(1):42-50. PubMed ID: 14659354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase III study of intravenous vinorelbine in combination with epirubicin versus epirubicin alone in patients with advanced breast cancer: a Scandinavian Breast Group Trial (SBG9403).
    Ejlertsen B; Mouridsen HT; Langkjer ST; Andersen J; Sjöström J; Kjaer M;
    J Clin Oncol; 2004 Jun; 22(12):2313-20. PubMed ID: 15197192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination regimen of epirubicin, vinorelbine and 5-fluorouracil continuous infusion as first-line chemotherapy in anthracycline-naive metastatic breast cancer patients.
    Berruti A; Bitossi R; Bottini A; Bonardi S; Donadio M; Nigro C; Bertetto O; Danese S; Bertone E; Sarobba MG; Farris A; Katsaros D; Castiglione F; Volpe T; Lattuada S; Mancarella S; Dogliotti L
    Eur J Cancer; 2005 Jan; 41(2):249-55. PubMed ID: 15661550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase I/II study of vinorelbine, doxorubicin, and methotrexate with leucovorin rescue as first-line treatment for metastatic breast cancer.
    Subramanyan S; Abeloff MD; Bond SE; Davidson NE; Fetting JH; Gordon GB; Kennedy MJ
    Cancer Chemother Pharmacol; 1999; 43(6):497-502. PubMed ID: 10321510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I study of epirubicin plus vinorelbine with or without G-CSF in advanced non-small cell lung cancer.
    Gridelli C; De Placido S; Pepe R; Incoronato P; Airoma G; Rossi A; Palazzolo G; Bianco AR
    Eur J Cancer; 1993; 29A(12):1729-31. PubMed ID: 7691117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary chemotherapy with epirubicin and vinorelbine in women with locally advanced breast cancer.
    Nisticò C; De Matteis A; Rossi E; Carnino F; Valenza R; Agostara B; Bria E; Farris A; Cremonesi M; D'Ottavio AM; Vaccaro A; Garufi C; Giunta S; Botti C; Perrone F; Terzoli E
    Anticancer Res; 2005; 25(2B):1343-8. PubMed ID: 15865089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity and safety of epirubicin plus paclitaxel in advanced breast cancer.
    Conte PF; Michelotti A; Baldini E; Tibaldi C; DaPrato M; Salvadori B; Giannessi PG; Gentile A; Biadi O; Mariani M
    Semin Oncol; 1996 Feb; 23(1 Suppl 1):28-32. PubMed ID: 8629033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
    Masters GA; Hoffman PC; Drinkard LC; Watson S; Samuels BL; Golomb HM; Vokes EE
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An escalating dose finding study of liposomal doxorubicin and vinorelbine for the treatment of refractory or resistant epithelial ovarian cancer.
    Tambaro R; Greggi S; Iaffaioli RV; Rossi A; Pisano C; Manzione L; Ferrari E; Di Maio M; Iodice F; Casella G; Laurelli G; Pignata S
    Ann Oncol; 2003 Sep; 14(9):1406-11. PubMed ID: 12954580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II study of epirubicin, vinorelbine and cisplatin in advanced breast cancer.
    Garrone O; Principe E; Occelli M; Mercuri M; Numico G; Granetto C; Di Costanzo G; Rattazzi PD; Merlano M
    Anticancer Drugs; 2004 Jan; 15(1):23-7. PubMed ID: 15090739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I studies of fluorouracil, doxorubicin and vinorelbine without (FAN) and with (SUPERFAN) folinic acid in patients with advanced breast cancer.
    Goss PE; Fine S; Gelmon K; Rudinskas L; Ottaway J; Myles J; James K; Paul K; Rodgers A; Pritchard KI
    Cancer Chemother Pharmacol; 1997; 41(1):53-60. PubMed ID: 9443614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epirubicin-vinorelbine intravenous combination followed by oral vinorelbine as first-line treatment in metastatic breast cancer.
    Ardizzoia A; Colombo I; Giordano M; Aglione S; Isa L; Scanni A; Scognamiglio G; Bertolini A; Villa F; Gardani G
    Tumori; 2007; 93(6):544-9. PubMed ID: 18338487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-line treatment with epirubicin and vinorelbine in metastatic breast cancer.
    Vici P; Colucci G; Gebbia V; Amodio A; Giotta F; Belli F; Conti F; Gebbia N; Pezzella G; Valerio MR; Brandi M; Pisconti S; Durini E; Giannarelli D; Lopez M
    J Clin Oncol; 2002 Jun; 20(11):2689-94. PubMed ID: 12039931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: a phase II study.
    Gasparini G; Caffo O; Barni S; Frontini L; Testolin A; Guglielmi RB; Ambrosini G
    J Clin Oncol; 1994 Oct; 12(10):2094-101. PubMed ID: 7931479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I study of vinorelbine and carboplatin combination in patients with taxane and anthracycline pretreated advanced breast cancer.
    Kosmas C; Agelaki S; Giannakakis T; Mavroudis D; Kouroussis Ch; Kalbakis K; Papadouris S; Souglakos J; Malamos N; Georgoulias V
    Oncology; 2002; 62(2):103-9. PubMed ID: 11914594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of a phase III prospective, randomised trial, comparing mitoxantrone and vinorelbine (MV) in combination with standard FAC/FEC in front-line therapy of metastatic breast cancer.
    Namer M; Soler-Michel P; Turpin F; Chinet-Charrot P; de Gislain C; Pouillart P; Delozier T; Luporsi E; Etienne PL; Schraub S; Eymard JC; Serin D; Ganem G; Calais G; Maillart P; Colin P; Trillet-Lenoir V; Prevost G; Tigaud D; Clavère P; Marti P; Romieu G; Wendling JL
    Eur J Cancer; 2001 Jun; 37(9):1132-40. PubMed ID: 11378344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential docetaxel followed by epirubicin-vinorelbine as first-line chemotherapy in advanced breast cancer.
    Vici P; Foggi P; Colucci G; Capomolla E; Brandi M; Giotta F; Gebbia N; Di Lauro L; Valerio MR; Paoletti G; Belli F; Pizza C; Giannarelli D; Lopez M
    Anticancer Res; 2005; 25(2B):1309-14. PubMed ID: 15865083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.